Waters Corp (WAT) Stock Price, Quote & News

Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It designs, manufactures, sells, and services thermal analysis, rheometry, and calor...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 508 478 2000

Fax: 508 872 1990

Website: www.waters.com

Address:

34 Maple Street, Milford, United States

PickAlpha Jan. 28 at 12:53 PM

PickAlpha Morning Report - Company News: 2026.01.28 News Analysis - 1/6: BD sets record date and final terms for tax‑efficient spin-off and Reverse Morris Trust merger with Waters | View: Transaction terms, tax ruling, and approvals reduce deal risk and clarify value transfer… $BDX $WAT $XLV $XHE

0 · Reply

Investor6 Jan. 27 at 3:55 PM

$WAT Waters Corp. Tuesday announced that its shareholders have approved the issuance of Waters common stock to shareholders of Becton, Dickinson and Company $BDX as part of the proposed combination of the latter's Biosciences & Diagnostic Solutions business with the company. With this approval, the company is planning to close the transaction on February 9, 2026. In other M&A news, BARK received a second buyout offer by Marcus Lemonis for $1.10 per share, with the first from the CEO standing at $0.90. The current sp of BARK is at $0.88.

0 · Reply

BillionerOfKing Jan. 14 at 6:06 PM

$WAT Current Stock Price: $394.35

0 · Reply

SuperGreenToday Jan. 13 at 9:41 PM

$WAT Share Price: $393.88 Contract Selected: Aug 21, 2026 $470 Calls Buy Zone: $6.71 – $8.29 Target Zone: $11.82 – $14.45 Potential Upside: 66% ROI Time to Expiration: 219 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

ortega1963 Dec. 20 at 3:17 PM

$WAT Keep an eye on this stock

0 · Reply

ffdseh Dec. 19 at 5:14 AM

$WAT

0 · Reply

JFDI Dec. 18 at 9:37 PM

$WAT ...wtf

0 · Reply

haileyhughes11 Dec. 15 at 7:38 PM

$WAT BioMainz VWAP 1.033 is the switch: flip it to support and asks start getting pulled because liquidity is thin 📊

0 · Reply

JarvisFlow Dec. 15 at 6:32 PM

Wells Fargo has adjusted their stance on Waters ( $WAT ), setting the rating to Equal-Weight with a target price of 385 → 415.

0 · Reply

JarvisFlow Dec. 10 at 4:27 PM

Wolfe Research has updated their rating for Waters ( $WAT ) to Outperform with a price target of 48.

0 · Reply

BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business

BDX

Jan 27, 2026, 9:25 AM EST - 2 days ago

Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business

BDX

Jan 20, 2026, 1:00 PM EST - 9 days ago

Waters Corporation Schedules Fourth Quarter 2025 Earnings Conference Call

Jan 19, 2026, 10:30 PM EST - 9 days ago

Artisan Mid Cap Fund Q4 2025 Performance Discussion And Portfolio Activity

ALAB ARGX COHR CRM CVNA DASH FERG

Jan 12, 2026, 7:46 PM EST - 16 days ago

Waters Corporation (WAT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Dec 23, 2025, 11:00 AM EST - 5 weeks ago

Waters Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026

Nov 18, 2025, 12:18 PM EST - 2 months ago

Waters Corporation (WAT) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 11, 2025, 2:00 PM EST - 2 months ago

Waters Corporation to Present at the Jefferies Global Healthcare Conference in London

Nov 11, 2025, 8:00 AM EST - 2 months ago

Waters Boosts Lab Productivity and Sample Throughput with Launch of its Charged Aerosol Detector Designed for Empower Software

Nov 5, 2025, 12:06 PM EST - 3 months ago

The London Company SMID Cap Vs. Russell 2500 Q3 2025 Top Contributors And Detractors

AWI CWST JKHY NEU SGI

Nov 4, 2025, 11:56 AM EST - 3 months ago

Waters Corporation (WAT) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 7:10 AM EST - 3 months ago

Waters Corp raises annual profit forecast on stronger lab equipment demand

Nov 4, 2025, 6:00 AM EST - 3 months ago

Waters Corporation (NYSE: WAT) Reports Third Quarter 2025 Financial Results

Oct 13, 2025, 8:05 AM EDT - 3 months ago

Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics

Oct 1, 2025, 12:00 PM EDT - 4 months ago

Waters Corporation Schedules Third Quarter 2025 Earnings Conference Call

Sep 4, 2025, 11:59 AM EDT - 5 months ago

Waters Corporation (WAT) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)

Aug 26, 2025, 4:10 PM EDT - 5 months ago

Waters Corporation to Present at the Wells Fargo Healthcare Conference

Aug 4, 2025, 11:05 AM EDT - 6 months ago

Waters Corporation (WAT) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 6:00 AM EDT - 6 months ago

Waters Corporation (NYSE: WAT) Reports Second Quarter 2025 Financial Results

Jul 16, 2025, 11:33 AM EDT - 7 months ago

WATERS CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT

BDX

Jul 14, 2025, 1:05 PM EDT - 7 months ago

Top Stock Movers Now: Autodesk, Fortinet, Waters, and More

ADSK FTNT

Jul 14, 2025, 11:20 AM EDT - 7 months ago

Analytics Equipment Maker Waters Buys Becton Dickinson Unit in a $17.5B Deal

Jul 14, 2025, 6:15 AM EDT - 7 months ago

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

BDX

Jul 11, 2025, 4:15 PM EDT - 7 months ago

Waters Corporation Schedules Second Quarter 2025 Earnings Conference Call

Jun 17, 2025, 10:00 AM EDT - 8 months ago

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity

Jun 2, 2025, 8:00 AM EDT - 8 months ago

Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer

May 28, 2025, 8:00 AM EDT - 8 months ago

Waters Introduces BioResolve Protein A Affinity Columns to Accelerate Antibody Titer Measurement, Enhancing Process Agility and Batch Quality

May 21, 2025, 8:00 AM EDT - 9 months ago

Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio

May 16, 2025, 11:00 AM EDT - 9 months ago

Waters Corporation to Present at the Jefferies Global Healthcare Conference

May 15, 2025, 7:48 AM EDT - 9 months ago

Waters Corp's India business boosted by rush for weight-loss drugs

May 6, 2025, 4:20 PM EDT - 9 months ago

Waters Corporation: Still A Hold After Q1 Earnings

May 6, 2025, 11:57 AM EDT - 9 months ago

Waters Corporation (WAT) Q1 2025 Earnings Call Transcript

May 6, 2025, 7:21 AM EDT - 9 months ago

Waters raises 2025 profit forecast on resilient demand for lab equipment

May 6, 2025, 6:15 AM EDT - 9 months ago

Waters Integrates Multi-Angle Light Scattering Detectors with Empower Software for Improved Biologics Quality Control and Simplified Regulatory Compliance

May 6, 2025, 6:00 AM EDT - 9 months ago

Waters Corporation (NYSE: WAT) Reports First Quarter 2025 Financial Results

Apr 29, 2025, 11:45 AM EDT - 9 months ago

Baron Health Care Fund Q1 2025 Top Net Purchases And Sales

ACLX ISRG MASI MCK NTRA PEN TMO

Apr 8, 2025, 4:30 PM EDT - 10 months ago

Waters Corporation Schedules First Quarter 2025 Earnings Conference Call

Apr 1, 2025, 8:00 AM EDT - 10 months ago

Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC

Mar 7, 2025, 1:00 PM EST - 11 months ago

Waters Corporation to Present at the Leerink Partners Global Healthcare Conference

Feb 21, 2025, 4:21 AM EST - 1 year ago

Waters Corporation: Instrument Replacement Cycle Momentum, But Valuation Is A Concern

Feb 12, 2025, 1:28 PM EST - 1 year ago

Waters Corporation (WAT) Q4 2024 Earnings Call Transcript

Feb 12, 2025, 6:00 AM EST - 1 year ago

Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2024 Financial Results

Feb 4, 2025, 8:00 AM EST - 1 year ago

Waters ElectroForce Apex 1 Instrument Offers Increased Versatility, Simplicity, and Speed to Mechanical Testing of Advanced Polymer Materials

Jan 29, 2025, 9:20 AM EST - 1 year ago

Weighing In On Waters Corporation: Facing A Valuation Headwind

Jan 22, 2025, 8:00 AM EST - 1 year ago

Innovative Waters TGA Smart-Seal Pans Enable Lower Cost, More Efficient Benchtop Analysis of Atmosphere-Sensitive Materials

Jan 17, 2025, 2:48 PM EST - 1 year ago

Waters Corporation Schedules Fourth Quarter 2024 Earnings Conference Call

Jan 10, 2025, 2:30 PM EST - 1 year ago

Waters Corporation to Host Investor Day on March 5, 2025

Dec 23, 2024, 8:19 AM EST - 1 year ago

Waters Corporation Named to Dow Jones Sustainability Index for the Fourth Consecutive Year

PickAlpha Jan. 28 at 12:53 PM

0 · Reply

Investor6 Jan. 27 at 3:55 PM

0 · Reply

BillionerOfKing Jan. 14 at 6:06 PM

$WAT Current Stock Price: $394.35

0 · Reply

SuperGreenToday Jan. 13 at 9:41 PM

0 · Reply

ortega1963 Dec. 20 at 3:17 PM

$WAT Keep an eye on this stock

0 · Reply

ffdseh Dec. 19 at 5:14 AM

$WAT

0 · Reply

JFDI Dec. 18 at 9:37 PM

$WAT ...wtf

0 · Reply

haileyhughes11 Dec. 15 at 7:38 PM

$WAT BioMainz VWAP 1.033 is the switch: flip it to support and asks start getting pulled because liquidity is thin 📊

0 · Reply

JarvisFlow Dec. 15 at 6:32 PM

Wells Fargo has adjusted their stance on Waters ( $WAT ), setting the rating to Equal-Weight with a target price of 385 → 415.

0 · Reply

JarvisFlow Dec. 10 at 4:27 PM

Wolfe Research has updated their rating for Waters ( $WAT ) to Outperform with a price target of 48.

0 · Reply

BillionerOfKing Dec. 2 at 10:40 PM

$WAT Current Stock Price: $398.72 Contracts to trade: $400 WAT Dec 19 2025 Call Entry: $5.00 Exit: $9.95 ROI: 99% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

JarvisFlow Dec. 2 at 6:05 PM

Morgan Stanley has adjusted their stance on Waters ( $WAT ), setting the rating to Equal-Weight with a target price of 423.

0 · Reply

Joshua_X Nov. 25 at 1:31 PM

Life Science Tools — Early Stabilization? Post: Some signs of stabilization in R&D spending. $IQV and $WAT showing relative strength. Keeping $PACB on watch for long-term innovation. Any other life-science names on your radar?

0 · Reply

NVDAMillionaire Nov. 18 at 10:57 AM

$WAT Outstanding article that hits the mark on WAT's current state. So if you want to refresh your WAT insights or learn about WAT from scratch, this is a must read. https://beyondspx.com/quote/WAT/analysis/waters-corporation-unlocking-growth-through-precision-and-strategic-expansion-wat

0 · Reply

sherowcap Nov. 7 at 1:42 PM

$BDX 10x earnings post the $WAT deal and sentiment remains bearish despite a new huge cost savings plan and at least 2B in buybacks coming in ‘26 plus debt repay from the cash in the deal. Easy buy under 180, FV 240-260 and low risk catalyst only weeks away

0 · Reply

IN0V8 Nov. 6 at 6:03 AM

$WAT Deutsche Bank raises target price to $335 from $330 Deutsche Bank raises target price to $355 from $335 Jefferies raises target price to $405 from $385 JP Morgan raises target price to $360 from $325 Leerink Partners raises target price to $400 from $355 Stifel raises target price to $380 from $360 TD Cowen raises target price to $390 from $345 Wells Fargo raises target price to $385 from $315

1 · Reply

JarvisFlow Nov. 5 at 6:37 PM

TD Cowen has updated their rating for Waters ( $WAT ) to Hold with a price target of 390.

0 · Reply

JarvisFlow Nov. 5 at 3:25 PM

Wells Fargo updates rating for Waters ( $WAT ) to Equal-Weight, target set at 315 → 385.

0 · Reply

Chuckthebear Nov. 4 at 5:01 PM

$WAT this didn’t age well 🥳

0 · Reply

Market Cap	23.23B
Revenue (ttm)	2.96B
Net Income (ttm)	637.83M
EPS (ttm)	N/A
PE Ratio	30.78
Forward PE	27.44
Profit Margin	21.56%
Debt to Equity Ratio	0.41

Volume	377,667
Avg Vol	516,006
Day's Range	N/A - N/A
Shares Out	59.55M
Stochastic %K	35%
Beta	1.16
Analysts	Sell
Price Target	$419.44